Tear fluid biomarker profiling: A review of multiplex bead analysis

Ocular Surface

Volumn 11, Issue 4, 2013, Pages 219-235

  Hagan, Suzanne ^a   Tomlinson, Alan ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

Bead arrays; Biomarkers; Chemokines; Cytokines; Diagnosis; Dry eye; Hyperosmolarity; Inflammation; Multiplex array; Tear film

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; CYTOKINE;

ARTICLE; CELL CULTURE; DRY EYE; ENZYME LINKED IMMUNOSORBENT ASSAY; GOLD STANDARD; LACRIMAL FLUID; NATURAL KILLER CELL; OCULAR SURFACE DISEASE; PHYSICAL DISEASE BY BODY FUNCTION; PROTEIN EXPRESSION; PROTEOMICS; T LYMPHOCYTE; TEAR FILM;

BEAD ARRAYS; BIOMARKERS; CHEMOKINES; CYTOKINES; DIAGNOSIS; DRY EYE; HYPEROSMOLARITY; INFLAMMATION; MULTIPLEX ARRAY; TEAR FILM;

BIOLOGICAL MARKERS; DRY EYE SYNDROMES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MICROSPHERES; POLYSTYRENES; TEARS;

EID: 84893807931     PISSN: 15420124     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtos.2013.04.004     Document Type: Review

References (103)

1. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5:75-92
2. Methodologies to diagnose and monitor ry eeye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;(5):108-52
3. Sullivan BD, Evans JE, Krenzer KL, et al. Impact of antiandrogen treatment on the fatty acid profile of neutral lipids in human meibomian gland secretions. J Clin Endocrinol Metab 2000;85:4866-73
4. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003;136: 318-26
5. Toda I, Asano-Kato N, Komai-Hori Y, Tsubota K. Dry eye after laser in situ keratomileusis. Am J Ophthalmol 2001;132:1-7
6. Glasson MJ, Stapleton F, Keay L, et al. Differences in clinical parameters and tear film of tolerant and intolerant contact lens wearers. Invest Ophthalmol Vis Sci 2003;44:5116-24
7. Tomlinson A, Lemp MA, Asbell PA. Dry Eye Disease. New York, Thieme, 2007. p. 1-15
8. Bron AJ, Yokoi N, Gafney E, Tiffany JM. Predicted phenotypes of dry eye: proposed consequences of its natural history. Ocul Surf 2009;7: 78-92
9. Schein OD, Muñoz B, Tielsch JM, et al. Prevalence of dry eye among the elderly. Am J Ophthalmol 1997;124:723-8
10. Sullivan BD, Evans JE, Dana MR, Sullivan DA. Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions. Arch Ophthalmol 2006;124:1286-92
11. Gilbard JP, Rossi SR. Changes in tear ion concentrations in dry-eye disorders. Adv Exp Med Biol 1994;350:529-33
12. Craig JP, Tomlinson A. Importance of the lipid layer in human tear film stability and evaporation. Optom Vis Sci 1997;74:8-13
13. Korb DR. Survey of preferred tests for diagnosis of the tear film and dry eye. Cornea 2000;19:483-6
14. Bron AJ. Diagnosis of dry eye. Surv Ophthalmol 2001;45:S221-6
15. McCann LC, Tomlinson A, Pearce EI, Papa V. Effectiveness of artificial tears in the management of evaporative dry eye. Cornea 2012;31:1-5
16. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea 2004;23: 762-70
17. Stern ME, Beuerman RW, Fox RI, et al. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 1998;17:584-9
18. Brignole F, Pisella PJ, Goldschild M, et al. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci 2000;41:1356-63
19. Barabino S, Rolando M, Camicione P, et al. Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea 2003;22:97-101
20. Stern ME, Siemasko KF, Gao J, et al. Evaluation of ocular surface inflammation in the presence of dry eye and allergic conjunctival disease. Ocul Surf 2005;3:S161-4
21. Pflugfelder SC, Stern SE. Immunoregulation on the ocular surface: 2nd Cullen Symposium. Ocul Surf 2009;7:67-77
22. Stern ME, Pflugfelder SC. Inflammation in dry eye. Ocul Surf 2004;2: 124-30
23. Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome study group. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 2006;25:900-7
24. Sullivan BD, Whitmer D, Nichols KK, et al. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci 2010;51:6125-30
25. Lemp MA, Bron AJ, Baudouin C, et al. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol 2011;151:792-8
26. Messmer EM, Bulgen M, Kampik A. Hyperosmolarity of the tear film in dry eye syndrome. Dev Ophthalmol 2010;45:129-38
27. Miller KL, Walt JG, Mink DR, et al. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol 2010;128:94-101
28. De Paiva CS, Villarreal AL, Corrales RM, et al. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon- gamma. Invest Ophthalmol Vis Sci 2007;48:2553-60
29. Chen Y, Chauhan SK, Saban DR, et al. Interferon-gamma-secreting NK cells promote induction of dry eye disease. J Leukoc Biol 2011;89:965-72
30. Chauhan SK, El Annan J, Ecoiffier T, et al. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol 2009;182: 1247-52
31. Zhang X, Volpe EA, Gandhi NB, et al. NK cells promote th-17 mediated corneal barrier disruption in dry eye. PLoS One 2012;7: e36822
32. Stern ME, Gao J, Schwalb TA, et al. Conjunctival T-cell subpopulations in Sjogren's and non-Sjogren's patients with dry eye. Invest Ophthalmol Vis Sci 2002;43:2609-14
33. El Annan J, Chauhan SK, Ecoiffier T, et al. Characterization of effector T cells in dry eye disease. Invest Ophthalmol Vis Sci 2009;50:3802-7
34. Zhang X, Chen W, De Paiva CS, et al. Desiccating stress induces CD4+ T-cell-mediated Sjogren's syndrome-like corneal epithelial apoptosis via activation of the extrinsic apoptotic pathway by interferon- gamma. Am J Pathol 2011;179:1807-14
35. Yoon KC, De Paiva CS, Qi H, et al. Expression of Th-1 chemokines and chemokine receptors on the ocular surface of C57BL/6 mice: Effects of desiccating stress. Invest Ophthalmol Vis Sci 2007;48:2561-9
36. Zhang X, Chen W, De Paiva CS, et al. Interferon-gamma exacerbates dry eye-induced apoptosis in conjunctiva through dual apoptotic pathways. Invest Ophthalmol Vis Sci 2011;52:6279-85
37. Calonge M, Enríquez-de-Salamanca A, Diebold Y, et al. Dry eye disease as an inflammatory disorder. Ocul Immunol Inflamm 2010;18:244-53
38. Enríquez-de-Salamanca A, Bonini S, Calonge M. Molecular and cellular biomarkers in dry eye disease and ocular allergy. Curr Opin Allergy Clin Immunol 2012 Aug 14 [Epub ahead of print]
39. Enriquez-de-Salamanca A, Calder V, Gao J, et al. Cytokine responses by conjunctival epithelial cells: an in vitro model of ocular inflammation. Cytokine 2008;44:160-7
40. Enríquez-de-Salamanca A, Calonge M. Cytokines and chemokines in immune-based ocular surface inflammation. Expert Rev Clin Immunol 2008;4:457-67
41. Solomon A, Dursun D, Liu Z, et al. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci 2001;42:2283-92
42. Lam H, Bleiden L, de Paiva CS, et al. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol 2009;147:198-205
43. Wakamatsu TH, Dogru M, Ayako I, et al. Evaluation of lipid oxidative stress status and inflammation in atopic ocular surface disease. Mol Vis 2010;16:2465-75
44. Massingale ML, Li X, Vallabhajosyula M, et al. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea 2009;28: 1023-7
45. Riemens A, Stoyanova E, Rothova A, Kuiper J. Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation. Mol Vis 2012;18:797-8
46. De Paiva CS, Hwang CS, Pitcher 3rd JD, et al. Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice. Rheumatology (Oxford) 2010;49:246-58
47. Narayanan S, Miller WL, McDermott AM. Conjunctival cytokine expression in symptomatic moderate dry eye subjects. Invest Ophthalmol Vis Sci 2006;47:2445-50.
48. Struyf S, Proost P, Van Damme J. Regulation of the immune response by the interaction of chemokines and proteases. Adv Immunol 2003;81:1-44
49. Shoji J, Inada N, Sawa M. Antibody array-generated cytokine profiles of tears of patients with vernal keratoconjunctivitis or giant papillary conjunctivitis. Jpn J Ophthalmol 2006;50:195-204
50. Shoji J, Kawaguchi A, Gotoh A, et al. Concentration of soluble interleukin-6 receptors in tears of allergic conjunctival disease patients. Jpn J Ophthalmol 2007;51:332-7
51. Sack R, Conradi L, Beaton A, et al. Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments. Exp Eye Res 2007;85:528-38
52. Li S, Sack R, Vijmasi T, et al. Antibody protein array analysis of the tear film cytokines. Optom Vis Sci 2008;85:653-60
53. Leonardi A, Tavolato M, Curnow SJ, et al. Cytokine and chemokine levels in tears and in corneal fibroblast cultures before and after excimer laser treatment. J Cataract Refract Surg 2009;35:240-7
54. Ferraccioli G, De Santis M, Peluso G, et al. Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. Autoimmun Rev 2010;9:622-6
55. Berrade L, Garcia AE, Camarero JA. Protein microarrays: novel developments and applications. Pharm Res 2011;28:1480-99
56. Yang L, Guo S, Li Y, et al. Protein microarrays for systems biology. Acta Biochim Biophys Sin (Shanghai) 2011;43:161-71
57. Boehm N, Riechardt AI, Wiegand M, et al. Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays. Invest Ophthalmol Vis Sci 2011;52:7725-30
58. Chan MF, Sack R, Quigley DA, et al. Membrane array analysis of tear proteins in ocular cicatricial pemphigoid. Optom Vis Sci 2011;88:1005-9
59. Knight PR, Sreekumar A, Siddiqui J, et al. Development of a sensitive microarray immunoassay and comparison with standard enzymelinked immunoassay for cytokine analysis. Shock 2004;21:26-30
60. Copeland S, Siddiqui J, Remick D. Direct comparison of traditional ELISAs and membrane protein arrays for detection and quantification of human cytokine. J Immunol Methods 2004;284:99-106
61. Alhamdani MS, Schroder C, Hoheisel JD. Analysis conditions for proteomic profiling of mammalian tissue and cell extracts with antibody microarrays. Proteomics 2010;10:3203-7
62. Enriquez-de-Salamanca A, Castellanos E, Stern ME, et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis 2010;16:862-73
63. Carreño E, Enríquez-de-Salamanca A, Tesón M, et al. Cytokine and chemokine levels in tears from healthy subjects. Acta Ophthalmol 2010;88:e250-8
64. Cook EB, Stahl JL, Lowe L, et al. Simultaneous measurement of six cytokines in a single sample of human tears using microparticlebased flow cytometry: allergics vs. non-allergics. J Immunol Methods 2001;254:109-18
65. Na KS, Mok JW, Kim JY, et al. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. Invest Ophthalmol Vis Sci 2012;53:5443-50
66. Gonzalez-Garcia MJ, Gonzalez-Saiz A, de la Fuente B, et al. Exposure to a controlled adverse environment impairs the ocular surface of subjects with minimally symptomatic dry eye. Invest Ophthalmol Vis Sci 2007;48:4026-32
67. Huang JF, Zhang Y, Rittenhouse KD, et al. Evaluations of tear protein markers in dry eye disease: repeatability of measurement and correlation with disease. Invest Ophthalmol Vis Sci 2012;53: 4556-64
68. González-Pérez J, Villa-Collar C, Sobrino Moreiras T, et al. Tear film inflammatory mediators during continuous wear of contact lenses and corneal refractive therapy. Br J Ophthalmol 2012;96:1092-8
69. Villani E, Galimberti D, Del Papa N, et al. Inflammation in dry eye associated with rheumatoid arthritis: Cytokine and in vivo confocal microscopy study. Innate Immun 2013 Jan 22 [Epub ahead of print]
70. Poyraz C, Irkec M, Mocan MC. Elevated tear interleukin-6 and interleukin-8 levels associated with silicone hydrogel and conventional hydrogel contact lens wear. Eye Contact Lens 2012;38:146-9
71. Kang MH, Kim MK, Lee HJ, et al. Interleukin-17 in various ocular surface inflammatory diseases. J Korean Med Sci 2011;26:938-44
72. Chotikavanich S, de Paiva CS, Li de Q, et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci 2009;50:3203-9
73. Leonardi A, Brun P, Tavolato M, et al. Tumor necrosis factor-alpha (TNF-alpha) in seasonal allergic conjunctivitis and vernal keratoconjunctivitis. Eur J Ophthalmol 2003;13:606-10
74. Pflugfelder SC, Jones D, Ji Z, et al. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res 1999;19:201-11
75. VanDerMeid KR, Su SP, Ward KW, Zhang JZ. Correlation of tear inflammatory cytokines and matrix metalloproteinases with four dry eye diagnostic tests. Invest Ophthalmol Vis Sci 2012;53:1512-8
76. Lee H, Min K, Kim EK, Kim TI. Minocycline controls clinical outcomes and inflammatory cytokines in moderate and severe meibomian gland dysfunction. Am J Ophthalmol 2012;154:949-57
77. Teson M, Gonzalez-Garcia MJ, Lopez-Miguel A, et al. Influence of a controlled environment simulating an in-flight airplane cabin on dry eye disease. Invest Ophthalmol Vis Sci 2013;54:2093-9
78. Li Z, Woo JM, Chung SW, et al. Therapeutic effect of topical adiponectin in a mouse model of desiccating stress-induced dry eye. Invest Ophthalmol Vis Sci 2013;54:155-62
79. Huang JF, Yafawi R, Zhang M, et al. Immunomodulatory effect of the topical ophthalmic janus kinase inhibitor Tofacitinib (CP-690,550) in patients with dry eye disease. Ophthalmology 2012;119:e43-50
80. Runström G, Mann A, Tigh B. The Fall and Rise of Tear Albumin Levels: A Multifactorial Phenomenon. Ocul Surf 2013;11:165-80
81. VanDerMeid KR, Su SP, Krenzer KL, et al. A method to extract cytokines and matrix metalloproteinases from Schirmer strips and analyze using Luminex. Mol Vis 2011;17:1056-63
82. Denisin AK, Karns K, Herr AE. Post-collection processing of Schirmer strip-collected human tear fluid impacts protein content. Analyst 2012;137:5088-96
83. Markoulli M, Papas E, Petznick A, Holden B. Validation of the flush method as an alternative to basal or reflex tear collection. Curr Eye Res 2011;36:198-207.
84. Inic-Kanada A, Nussbaumer A, Montanaro J, et al. Comparison of ophthalmic sponges and extraction buffers for quantifying cytokine profiles in tears using Luminex technology. Mol Vis 2012;18:2717-25
85. Posa A, Bräuer L, Schicht M, et al. Schirmer strip vs. capillary tube method: Non-invasive methods of obtaining proteins from tear fluid. Ann Anat 2013;195:137-42
86. Markoulli M, Papas E, Cole N, Holden BA. The diurnal variation of matrix metalloproteinase-9 and its associated factors in human tears. Invest Ophthalmol Vis Sci 2012;53:1479-84
87. Choi W, Li Z, Oh HJ, et al. Expression of CCR5 and its ligands CCL3, -4, and -5 in the tear film and ocular surface of patients with dry eye disease. Curr Eye Res 2012;37:12-7
88. Puinhas A, Sampaio P, Castanheira EM, et al. Comparison of IgA, TNF-a and surface tension of the tear film in two different times of the day. Cont Lens Anterior Eye 2013;36:140-5
89. Elshal MF, McCoy JP. Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods 2006;38: 317-23
90. duPont NC, Wang K, Wadhwa PD, et al. Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. J Reprod Immunol 2005;66:175-91
91. Codorean E, Nichita C, Albulescu L, et al. Correlation of XMAP and ELISA cytokine profiles; development and validation for immunotoxicological studies in vitro. Roum Arch Microbiol Immunol 2010;69:13-9
92. Richens JL, Urbanowicz RA, Metcalf R, et al. Quantitative validation and comparison of multiplex cytokine kits. J Biomol Screen 2010;15:562-8
93. de Jager W, Rijkers GT. Solid-phase and bead-based cytokine immunoassay: A comparison. Methods 2006;38:294-303
94. Goldblatt D, Ashton L, Zhang Y, et al. Comparison of a new multiplex binding assay versus the enzyme-linked immunosorbent assay for measurement of serotype-specific pneumococcal capsular polysaccharide IgG. Clin Vaccine Immunol 2011;18:1744-51
95. Bomert M, Köllisch G, Roponen M, et al. Analytical performance of a multiplexed, bead-based cytokine detection system in small volume samples. Clin Chem Lab Med 2011;49:1691-3
96. Chiswick EL, Duffy E, Japp B, Remick D. Detection and quantification of cytokines and other biomarkers. Methods Mol Biol 2012;844:15-30
97. Fu Q, Zhu J, Van Eyk JE. Comparison of multiplex immunoassay platforms. Clin Chem 2010;56:314-8
98. Chowdhury F, Williams A, Johnson P. Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling. J Immunol Methods 2009;340:55-64
99. Dupuy AM, Kuster N, Lizard G, et al. Performance evaluation of human cytokines profiles obtained by various multiplexed-based technologies underlines a need for standardization. Clin Chem Lab Med 2013;9:1-9
100. Kuizenga A, van Haeringen NJ, Meijer F, Kijlstra A. Analysis of human tear fluid components, inhibiting protein adhesion to plastic surfaces. Exp Eye Res 1996;63:319-28
101. Poethke R, Mäder M, Zedler I, et al. A putative enzyme from various secretions specifically inhibits antibody-antigen interactions. J Immunol Methods 1996;191:149-57
102. Ellington AA, Kullo IJ, Bailey KR, Klee GG. Measurement and quality control issues in multiplex protein assays: A case study. Clinical Chemistry 2009;55:1092-9
103. Mire-Sluis AR, Barrett YC, Devanarayan V, et al. Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products. J Immunol Methods 2004;289:1-16